Precision Medicine
Found 2 companies.
🏢 Roche
💰 $5.0B Post-IPO Equity on 2021-08-04🫂 on 2023-05-10PharmaceuticalBiotechnologyPrecision MedicineHealth CareHealth Diagnostics
Website LinkedIn Phone # Facebook Twitter

Roche is a leading pharmaceutical and diagnostics company that specializes in providing in-vitro diagnostics and drugs for cancer and transplantation. With a wide range of products and solutions, Roche aims to improve people's lives by focusing on oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology.

🏢 Bristol Myers Squibb
💰 $4.5B Post-IPO Debt on 2023-10-30🫂 on 2023-08-11PharmaceuticalBiotechnologyMedicalPrecision MedicineHealth Care
Website LinkedIn Phone # Facebook Twitter

Bristol-Myers Squibb Company is a pharmaceutical company focused on discovering, developing, and selling medicines for oncology, cardiovascular, immunoscience, and fibrosis, with a commitment to improving patient outcomes and quality of life.